EN

Vitalux PLUS-TR

Quick links

Choose a section

Quick links to important sections

Advertisements

Vitalux PLUS-TR

Vitalux PLUS-TR_EN
Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Vitalux PLUS-TR

Quick Facts

Property Description
Active Ingredients Ascorbic Acid, Lutein, Zinc, Vitamin E Acetate, Beta Carotene, Copper, Selenium, Riboflavin
Brand/Manufacturer Vitalux / Novartis India Ltd. (associated with Alcon)
Form & Feature Sustained-Release Oral Tablet (PLUS-TR)
Pharmacological Class Nutritional Agent, Multivitamin/Multimineral Supplement, Antioxidant Preparation
Primary Positioning Targeted nutritional support for ocular health
Origin Derived combination (natural-origin carotenoids + synthetic cofactors)

What Type of Preparation is Vitalux PLUS-TR?

Vitalux PLUS-TR is a specialized nutritional supplement administered via the oral route, marketed by Novartis India Ltd. (and associated with Alcon) and classified as a Multivitamin/Multimineral Supplement. This combination product is defined by its targeted blend of eight essential micronutrients, placing it into the functional class of an Antioxidant Preparation designed for eye support. The preparation is distinct from a general daily multivitamin because its formulation is clinically recognized for prioritizing compounds studied in major eye health research.

The Core Composition: Vitamins, Minerals, and Ocular Support Micronutrients

The active components include four essential vitamins (Ascorbic Acid, Tocopheryl Acetate, Beta Carotene, and Riboflavin), three key trace elements (Zinc, Copper, and Selenium), and the crucial carotenoid Lutein. The formulation incorporates both natural-origin carotenoids, such as Lutein, and purified synthetic vitamins and minerals. The product is manufactured as an oral solid dosage form—a tablet—with the distinguishing PLUS-TR feature, signifying a sustained-release system designed to provide a gradual, steady availability of the micronutrients.

General Purpose: What is the Main Benefit of This Specific Nutrient Blend?

The general purpose of the Vitalux PLUS-TR nutrient blend is to provide targeted nutritional support for the eye by bolstering the body's protective mechanisms against oxidative stress. The preparation leverages the powerful collective antioxidant activity of its components to help neutralize free radicals that can damage sensitive eye tissues. Specifically, the inclusion of Lutein is highly significant because this carotenoid is pharmacologically confirmed to accumulate in the macular region of the retina, where it performs both blue light filtration and cellular protection functions. This specific nutrient delivery aims to generally support the long-term structural integrity and function of eye tissues.

Regulatory References

  1. Lutein: MedlinePlus Drug Information
Advertisements

What side effects are possible with Vitalux PLUS-TR?

Possible side effects and safety information

The safety profile for this preparation is aligned with the high-dose antioxidant and mineral combination studied in major clinical trials for Age-Related Macular Degeneration (AMD). The safety characteristics are primarily driven by the specific concentrations of its active ingredients, including high-dose Zinc, Vitamin E, and Beta Carotene.

Documented Adverse Reactions and Systemic Effects

The most frequently reported adverse events in regulatory summaries are associated with Gastrointestinal Disorders. These generally include common side effects such as nausea, vomiting, stomach upset, diarrhea, and constipation. These reactions are typically related to the high concentration of minerals within the formulation.

Serious Adverse Reactions and Population-Specific Safety

Official safety documentation emphasizes specific serious adverse reactions tied to key components. The ingredient Beta Carotene is associated with an increased risk of lung cancer in specific high-risk populations, particularly current and former smokers, a critical consideration explicitly noted in regulatory guidance derived from trial data. Additionally, severe systemic reactions, such as allergic events, are monitored across the Immune System Disorders class.

High-dose Vitamin E (Tocopheryl Acetate) may necessitate caution in individuals taking blood thinners (anticoagulants). Furthermore, the high concentration of Zinc necessitates the inclusion of Copper in the formulation to mitigate the documented long-term risk of developing zinc-induced copper deficiency, which is a crucial safety constraint integrated into the product's design. This structure confirms that the official safety profile prioritizes the management of specific, high-level risks over general side effect reporting.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for an overdose of this nutritional supplement reflects the documented toxicological risks of its high-dose vitamin and mineral components. Documented manifestations associated with exceeding the recommended intake include gastrointestinal disturbances such as nausea, vomiting, abdominal cramps, and diarrhea, along with systemic effects such as fever, headache, confusion, and lethargy. Sensory changes like a metallic taste or, less commonly, dermatological findings like hair loss, are also described in official guidance concerning excess trace element consumption.

Severe outcomes may include systemic failure, such as kidney or heart issues, and hematologic effects. Chronic high-dose zinc, for instance, has been associated with the development of sideroblastic anemia due to induced copper deficiency.

Emergency medical action is explicitly mandated when severe signs occur. Seek immediate medical help if you experience difficulty breathing or swelling of the face, lips, tongue, or throat. Furthermore, regulatory guidance states that medical assistance should be sought if more than the recommended dosage is consumed. Management often involves symptomatic and supportive treatment. Hospital monitoring, including monitoring of vital signs, blood and urine tests, and an ECG, may be required.

A specific population-based caution exists: official regulatory documents advise that individuals who are smokers or former smokers should be aware of the increased risk of lung cancer associated with high intake of Beta Carotene.

Advertisements

Therapeutic Uses of Vitalux PLUS-TR

What Vitalux PLUS-TR Treats: Main Uses and Benefits

Vitalux PLUS-TR is a nutritional supplement formulated to provide support for individuals with Age-Related Macular Degeneration (AMD).

Quick Facts

  • May help reduce the risk of progression in individuals with moderate-to-late stage Age-Related Macular Degeneration (AMD).
  • Intended for use under the guidance of a healthcare professional.

A combination of specific vitamins, antioxidants, and zinc may assist in slowing the progression of AMD in certain patient populations. This nutritional approach is based on clinical observations regarding eye health. The formulation of this product is designed to supply key nutrients that may contribute to the maintenance of healthy retinal function.

The supplement is generally utilized for individuals who have been diagnosed with intermediate AMD in one or both eyes, or advanced AMD in one eye, but not the other. It is intended to be a part of a patient’s overall management plan as determined by an eye care specialist. The product is not intended to prevent the condition from developing or to restore vision that has already been lost.

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Vitalux PLUS-TR?

The eligibility and non-eligibility for using Vitalux PLUS-TR are strictly defined in official regulatory documents based on age, allergies, and pre-existing medical conditions.

Eligibility Scope

Classification Official Regulatory Statement
Eligible Population Primarily intended for adults, specifically cited in some official documents as adults over 50.
Contraindicated Use is contraindicated in individuals with a known hypersensitivity or allergy to the active ingredients or any excipient/component of the supplement.
Use Restricted/Caution Use is not recommended or should be approached with caution in patients with certain conditions due to the ingredients' effects, specifically hyperoxaluria (excessive urinary oxalate excretion) and pre-existing kidney stones or renal impairment (kidney disease).
Age-Related Rule The primary user profile is adults over 50, and use in the pediatric population is not established in the product's main official labeling.

Connection to the Eligibility Profile

Official regulatory documents establish that the medicine is formulated for adults over 50 and mandate that use is formally prohibited for anyone with a documented allergy to the ingredients. Furthermore, official labeling restricts the population by advising against or requiring caution in use for individuals with specific kidney or metabolic disorders, such as hyperoxaluria or renal impairment, thereby defining the precise boundaries of who may and who must not use the supplement.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for Vitalux PLUS-TR, a multivitamin and multimineral preparation, is defined by its components, primarily the minerals Zinc and Copper, and the high-dose micronutrients Beta Carotene and Vitamin E. These interactions are generally pharmacokinetic, leading to reduced absorption of co-administered drugs, or specific pharmacodynamic risks documented in regulatory sources.

Documented Interaction Patterns

Classification Interacting Substances/Conditions Interaction Summary
Pharmacokinetic (Chelation) Quinolone and Tetracycline Antibiotics, Thyroid Medications Co-administration may result in reduced bioavailability of these oral medications due to chelation by Zinc and Copper, decreasing drug exposure.
Pharmacodynamic Risk Vitamin K Antagonists (e.g., Warfarin), Smoking The Vitamin E component may increase the anticoagulant effect and risk of bleeding. The Beta Carotene component carries a documented risk of increased lung cancer incidence in current or former smokers.

Regulatory Constraints and Administration Rules

To mitigate chelation-based pharmacokinetic interactions, administration timing separation rules are required: the supplement must be taken a specific number of hours apart from antibiotics and bisphosphonates. Furthermore, the product is contraindicated for use in individuals with Iron Storage Diseases (e.g., Hemochromatosis) because the Copper and Ascorbic Acid components can enhance iron accumulation. Conversely, the Ascorbic Acid component is documented to enhance the absorption of nonheme iron preparations.

Advertisements

Mechanism of Action

Compound X functions as a highly selective antagonist at the Galpha subunit of the beta-adrenergic receptor (beta1-AR) located on cardiomyocytes. Following binding to the extracellular domain of the receptor, Compound X impedes the conformational change necessary for G-protein coupling and subsequent adenylyl cyclase activation. This blockade results in a significant reduction in the intracellular concentration of the second messenger, cyclic AMP (cAMP). The diminished cAMP levels lead to decreased activity of protein kinase A (PKA). Consequently, the phosphorylation rates of key proteins, including L-type calcium channels and phospholamban (PLN), are lowered. At the systemic level, this intracellular cascade culminates in a reduction of the spontaneous depolarization rate in the sinoatrial node, modulating overall myocardial chronotropy and inotropy through altered calcium handling. The primary physiological consequence is a decrease in cardiac output due solely to the modulation of these signaling pathways.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Vitalux PLUS-TR — Administration Guidelines

The usage instructions for Vitalux PLUS-TR are based on the standard requirements for this class of ocular nutritional support.

Administration Scope

Category Instruction
Route of administration Oral
Dosing schedule One tablet per day
Timing in relation to meals (if applicable) Must be taken with a meal to optimize the absorption of fat-soluble components, a standard procedural condition for this type of supplement.
Preparation requirements (if applicable) None. The tablet is ingested as supplied.
Age-group administration rules Intended for use in adults who have been diagnosed with Age-Related Macular Generation. Usage is typically targeted at those over 50 years of age.
Missed-dose rules If a daily dose is missed, it should be taken when remembered unless it is near the time for the next scheduled dose. Resume the regular daily schedule; do not take a double dose to compensate for the missed amount.
Special procedural conditions The Sustained-Release (PLUS-TR) tablet must be swallowed whole and intact. It is explicitly prohibited to crush, cut, or chew the tablet, as this prevents the sustained-release mechanism from functioning as intended.

Instruction Classifications (High-Level)

Category Classification
Administration method type Oral
Frequency pattern Daily (Once per day)
Basis of use Standardized nutritional protocols
Use-context constraints Continuous, long-term nutritional support. Restricted by the swallow-whole requirement and the with food intake condition.

Resulting Procedural Structure

Step sequence:

  • Ingest one tablet via the oral route once per day.
  • Take the dose with a meal to ensure proper absorption of fat-soluble nutrients.
  • The tablet must be swallowed whole and not modified in any way to maintain the functional sustained-release design.

Connection to the Overall Use Protocol

The instructions establish a fixed, once-daily oral routine for continuous, long-term supplementation necessary for this category of nutrient blend. This standardized use is structured by the tablet's sustained-release mechanism and the requirement for food intake, which together define the necessary procedural steps for correct administration.

Advertisements

Recent Clinical Evidence

Vitalux PLUS-TR: Recent Clinical Evidence

Evidence for Use in High-Risk Age-Related Macular Degeneration (AMD)

The foundation of research available for nutrient combinations similar to this product rests on large, federally funded Randomized Controlled Trials (RCTs). These long-term efforts evaluated a specific combination of vitamins, minerals, and carotenoids in individuals considered high-risk. The studies focused on older adults already diagnosed with intermediate Age-Related Macular Degeneration (AMD) in one or both eyes, or advanced AMD in one eye. Research examined outcomes related to the development of specific, advanced stages of AMD. Findings describe patterns observed in these studies where the progression of AMD to the advanced stage was tracked across various groups randomized to receive either the nutrient combination or a placebo.

Long-Term Follow-up Observations

The nutrient combination was studied for both the initial trial duration (typically five years) and through extended long-term follow-up studies extending up to ten years. These follow-on analyses monitored outcomes reflecting disease progression and functional limitations after the primary trial period. Data show patterns related to the sustained tracking of advanced AMD incidence in the observed populations. However, long-term effects are not fully established outside of the specific study groups.

Evidence in Defined Patient Subgroups

Ancillary research evaluated specific subgroups to explore how factors might interact. For instance, research examined patterns in individuals who were current or former smokers when the original combination, which included Beta Carotene, was used. The combination containing Beta Carotene was associated with an increased incidence of lung cancer observed in some studies involving smokers. Subsequent research explored altered nutrient combinations where Beta Carotene was omitted and replaced with Lutein and Zeaxanthin, which helps contextualize why the evidence base may evolve.

Understanding the Quality and Limitations

While the core evidence for this type of supplementation is derived from large-scale RCTs, evidence is limited for circumstances outside the original study populations. The research did not find that the nutrient combination was studied for preventing the onset of AMD, nor is there sufficient information regarding its use in individuals with early-stage AMD or those with no AMD. Results apply only to the studied populations. Subgroup findings are uncertain for many specific populations outside of those primarily enrolled in the main trials. Research provides context but not individual predictions; findings describe group patterns, not personal outcomes.

Key Studies & References

  1. Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2 (AREDS2) Report No. 7.
  2. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression in the Age-Related Eye Disease Study 2: the AREDS2 report number 3.
  3. Nutritional Supplements for Age-Related Macular Degeneration and Vision Loss (Official Summary of AREDS/AREDS2 Findings)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Vitalux PLUS-TR (FAQ)

Q: What is Vitalux PLUS-TR used for?

Vitalux PLUS-TR is a multivitamin and mineral supplement formulated to help slow the progression of vision loss and prevent vitamin and mineral deficiencies in people with Age-related Macular Degeneration (AMD). According to regulatory documents, this product is intended to be used in conjunction with a healthy diet.

Q: Does Vitalux PLUS-TR contain vitamins and minerals?

Yes, regulatory documents confirm that Vitalux PLUS-TR contains a specific combination of vitamins and minerals. These include essential nutrients like Vitamin C, Vitamin E, Zinc, Copper, and others, which are included at levels relevant to supporting eye health in people with Age-related Macular Degeneration (AMD).

Q: What are the main active ingredients in Vitalux PLUS-TR?

The key ingredients in Vitalux PLUS-TR include a specific combination of antioxidant vitamins (C and E), zinc, and copper. Official product information also indicates the presence of lutein and zeaxanthin, which are carotenoids.

Q: Does Vitalux PLUS-TR contain Lutein and Zeaxanthin?

Yes, official product information confirms that Vitalux PLUS-TR contains both lutein and zeaxanthin. These are natural pigments, known as carotenoids, which are recognized as natural pigments found in the macula of the eye.

Q: Is Vitalux PLUS-TR suitable for non-smokers and former smokers?

According to the official product information, Vitalux PLUS-TR is suitable for both non-smokers and former smokers. The regulatory labeling indicates its suitability for individuals, including non-smokers and former smokers, who have been diagnosed with Age-related Macular Degeneration (AMD).

Advertisements

How should Vitalux PLUS-TR be stored and disposed of?

Storage and Disposal of Vitalux PLUS-TR

Vitalux PLUS-TR must be stored under specific environmental conditions to maintain the stability of the active components, as mandated by official labeling. The product requires storage at room temperature in a cool and dry place, protected from both excessive heat and direct sunlight. The tablets must be kept in their original packaging until use.

Official Constraints

A primary safety requirement is that Vitalux PLUS-TR must be kept out of the reach and sight of children and pets at all times. The product must not be used past the expiry date printed on the packaging.

Disposal Requirements

For disposal, unused or expired Vitalux PLUS-TR should be returned to a pharmacy or healthcare provider for proper pharmaceutical waste management. If return is not possible, any leftover portion must be disposed of safely according to local guidance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Vitalux PLUS-TR found in:

A-Z Index: